Meningioma risk stratification with a targeted gene-expression biomarker-Reference-Cited by-同舟云学术

Meningioma risk stratification with a targeted gene-expression biomarker

Published:2023-12 Issue:12 Volume:29 Page:3020-3021
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-023-02642-8.pdf

Reference6 articles.

1. Chen, W. C. et al. Radiotherapy and radiosurgery for meningiomas. Neurooncol. Adv. 5, i67–i83 (2023). A review that summarizes the literature on meningioma classification and treatment.

2. Choudhury, A. et al. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat. Genet. 54, 649–659 (2022). A study of meningioma molecular groups using DNA-methylation profiling.

3. Choudhury, A. et al. Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features. Neuro Oncol. 25, 520–530 (2023). A study of meningioma molecular subgroups using DNA-methylation profiling.

4. Patel, A. J. et al. Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors. Proc. Natl Acad. Sci. USA 116, 21715–21726 (2019). A study of meningioma molecular groups using RNA sequencing.

5. Nassiri, F. et al. A clinically applicable integrative molecular classification of meningiomas. Nature 597, 119–125 (2021). A paper reporting a meningioma molecular classification using DNA-methylation profiling, RNA sequencing, copy-number variants and somatic short variants.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene Expression Changes Associated With Recurrence After Gross Total Resection of Newly Diagnosed World Health Organization Grade 1 Meningioma;Neurosurgery;2024-08-05